Equity Profile

ADMA

ADMA Biologics, Inc.

Health CareBiotechnology$1.8B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

ADMA Biologics, Inc. operates in the health care sector, focusing on biotechnology....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will help gauge the company's financial health this quarter.

N/A

Revenue Growth

Revenue growth is crucial for understanding the company's market performance and demand for its products.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

ADMA Q2-2026 Earnings Preview

Context

Company Snapshot

ADMA Biologics, Inc. operates in the health care sector, focusing on biotechnology. The company is known for developing and manufacturing specialized immunoglobulin products that treat patients with immune deficiencies, making it a significant player in addressing critical health needs.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+30.88%

Avg Stock Reaction

+0.95%

Last Quarter Recap

In Q1-2026, ADMA reported an EPS of $0.19, which did not meet any analyst estimates. Following the announcement, the stock saw a slight decline of 1.66% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for ADMA's upcoming earnings are mixed, with no analyst estimates available to guide investors. The stock's recent performance has been volatile, reflecting uncertainty.

Bull Case

If ADMA can demonstrate strong revenue growth and maintain or improve its EPS, it could signal robust demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet expectations for revenue or EPS, it could lead to a significant drop in stock price, especially given the current market volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could heavily influence investor sentiment.

How has revenue changed compared to previous quarters?

Understanding revenue trends will provide insight into the company's growth trajectory and market demand for its products.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating ADMA's potential for revenue growth, particularly given its recent product launches and market expansion efforts.

Supporting Evidence

The company's historical EPS beat rate of 67% suggests a stronger performance than expected.

Options pricing indicates a significant move, which may reflect underlying confidence not captured in analyst estimates.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently weighing the company's ability to maintain profitability and grow revenue amid competitive pressures.

Bull Confirmed If

An EPS of $0.25 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $0.15 would confirm the bear case, suggesting ongoing struggles with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±26.39%

Historical Avg

±2.8%

Pricing rich

The options market is pricing in a significant move of over 26%, indicating that traders expect considerable volatility following the earnings report.

Options are pricing ±26.9% while ADMA has averaged ±2.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

61.6%

Calls (13K)P/C Ratio: 1.16Puts (800)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 12 of 25 (48%)

This setup has occurred 30 times across Health Care in the last 2 years. 12 of 25 faded and 13 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.0%, with a raw directional average of +0.5% (modestly positive historical bias).

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$318,360.00

21,000 sh

1 insider

Net

$318,360.00

Net selling

Most Active Insiders· 2 open-market trades

President and CEOGrossman Adam S
$318,360.00

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders adding

Institutional

97.01%

of float

Insider

1.85%

of float

Holders

474

institutions

Top Holders· as of Dec 2025

Blackrock Inc.
36,333,325 sh · $409.1M
15.64%
2.0%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ADMA beats expectations, history suggests the stock could rise by about 0.27%, confirming a positive outlook for the company.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance from management.

Miss

If the company misses expectations, history suggests a potential decline of around 3.59%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into customer demand trends and how they are affecting sales.
4Details on cost management strategies and their effect on profitability.
5Any guidance on future earnings expectations or strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

ADMA Biologics, Inc. operates in the health care sector, focusing on biotechnology....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will help gauge the company's financial health this quarter.

N/A

Revenue Growth

Revenue growth is crucial for understanding the company's market performance and demand for its products.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

ADMA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+30.88%

Avg Stock Reaction

+0.95%

Last Quarter Recap

In Q1-2026, ADMA reported an EPS of $0.19, which did not meet any analyst estimates. Following the announcement, the stock saw a slight decline of 1.66% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for ADMA's upcoming earnings are mixed, with no analyst estimates available to guide investors. The stock's recent performance has been volatile, reflecting uncertainty.

Bull Case

If ADMA can demonstrate strong revenue growth and maintain or improve its EPS, it could signal robust demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet expectations for revenue or EPS, it could lead to a significant drop in stock price, especially given the current market volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could heavily influence investor sentiment.

How has revenue changed compared to previous quarters?

Understanding revenue trends will provide insight into the company's growth trajectory and market demand for its products.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating ADMA's potential for revenue growth, particularly given its recent product launches and market expansion efforts.

Supporting Evidence

The company's historical EPS beat rate of 67% suggests a stronger performance than expected.

Options pricing indicates a significant move, which may reflect underlying confidence not captured in analyst estimates.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently weighing the company's ability to maintain profitability and grow revenue amid competitive pressures.

Bull Confirmed If

An EPS of $0.25 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $0.15 would confirm the bear case, suggesting ongoing struggles with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±26.39%

Historical Avg

±2.8%

Pricing rich

The options market is pricing in a significant move of over 26%, indicating that traders expect considerable volatility following the earnings report.

Options are pricing ±26.9% while ADMA has averaged ±2.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

61.6%

Calls (13K)P/C Ratio: 1.16Puts (800)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 12 of 25 (48%)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$318,360.00

21,000 sh

1 insider

Net

$318,360.00

Net selling

Most Active Insiders· 2 open-market trades

President and CEOGrossman Adam S
$318,360.00

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders adding

Institutional

97.01%

of float

Insider

1.85%

of float

Holders

474

institutions

Top Holders· as of Dec 2025

Blackrock Inc.
36,333,325 sh · $409.1M
15.64%
2.0%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ADMA beats expectations, history suggests the stock could rise by about 0.27%, confirming a positive outlook for the company.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance from management.

Miss

If the company misses expectations, history suggests a potential decline of around 3.59%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into customer demand trends and how they are affecting sales.
4Details on cost management strategies and their effect on profitability.
5Any guidance on future earnings expectations or strategic initiatives.